Skip to search formSkip to main contentSkip to account menu

Phosphodiesterase 5 inhibitor

Known as: Phosphodiesterase V Inhibitor, Inhibitors, PDE5, PDE 5 Inhibitors 
Compounds that specifically inhibit PHOSPHODIESTERASE 5.
National Institutes of Health

Related topics

Related topics

11 relations
In Bloodaspects of radiation effectscGMP Phosphodiesterase Inhibitorchemical synthesis

Broader (1)

Phosphodiesterase 5 Inhibitor [EPC]

Narrower (5)

Sildenafil citratemirodenafiltadalafiludenafil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effects of phosphodiesterase 5 inhibitor sildenafil on the respiratory parameters, inflammation and apoptosis in a saline lavage-induced model of acute lung injury.
Acute lung injury (ALI) is associated with deterioration of alveolar-capillary lining and transmigration and activation of… 
Review
2012
Review
2012
Effect of tunical defect size after Peyronie's plaque excision on postoperative erectile function: do centimeters matter?
Highly Cited
2010
Highly Cited
2010
Clinical Potential of Combined Organic Nitrate and Phosphodiesterase Type 5 Inhibitor in Treatment-Resistant Hypertension
NO donor drugs (eg, isosorbide mononitrate; ISMN) and phosphodiesterase 5 inhibitors (eg, sildenafil) have antihypertensive… 
Highly Cited
2010
Highly Cited
2010
ORIGINAL RESEARCH—ERECTILE DYSFUNCTION Predicting Erectile Function Recovery after Bilateral Nerve Sparing Radical Prostatectomy: A Proposal of a Novel Preoperative Risk Stratification
Introduction. No multivariable model is currently available for the prediction of erectile function (EF) recovery after bilateral… 
2008
2008
Sexuality and older people
Doctors should ask patients, regardless of age, about sex 
2007
2007
Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study
Aims:  This report describes patterns of treatment changes with the phosphodiesterase type 5 (PDE5) inhibitors tadalafil… 
2005
2005
Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
INTRODUCTION A number of preference studies have been conducted with phosphodiesterase type 5 (PDE5) inhibitor medications… 
Highly Cited
2003
Highly Cited
2003
Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery
Sildenafil (viagra) is a potent PDE5 inhibitor and thus a relaxant drug in corpus carvernosum smooth muscle. In the present work… 
2001
2001
Urodilatin, a natriuretic peptide stimulating particulate guanylate cyclase, and the phosphodiesterase 5 inhibitor dipyridamole attenuate experimental pulmonary hypertension: synergism upon…
In a model of acute pulmonary hypertension in intact rabbits, we investigated the vasodilatory potency of intravascularly… 
1991
1991
Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)